Borres, Julia P.
HRN: 20-43-81 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/26/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/26/2025
07/03/2025
IV
100 Mg
Q 6 Hours
T/C Bullous Impetigo
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes